Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

ASTRAZENECA PLC ADRhedged

53.28
0.0000
Volume:- -
Turnover:- -
Market Cap:1.60M
PE:- -
High:53.28
Open:53.28
Low:53.28
Close:53.28
52wk High:56.90
52wk Low:44.36
Shares:30.00K
Float Shares:10.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:0.58
Dividend Rate:1.08%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

OverviewCompanyNewsFilings

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03

AstraZeneca Explores Blockbuster Bristol-Myers Squibb Deal Reshaping Global Pharma Landscape

Stock News
·
Aug 03

Astrazeneca, Daiichi Sankyo's Breast Cancer Therapy Receives EU approval

MT Newswires Live
·
Jul 31

Alnylam Lowers 2026 Outlook As Second-Line Amvuttra Demand Normalizes, Stock Tanks

Benzinga Earnings
·
Jul 31

Xencor Shares Rise After Settlement Deal With Alexion

MT Newswires Live
·
Jul 31

AstraZeneca’s DURGA-6 Trial Puts Cell Therapy in Direct Competition With Myeloma Transplants

TIPRANKS
·
Jul 31

AstraZeneca Slides Thursday, Underperforms Market

Dow Jones
·
Jul 31

AstraZeneca Shuts Down China NASH Registry: What It Means for AZN Investors

TIPRANKS
·
Jul 30

AstraZeneca Upbeat Internal Pipeline Can Drive Growth Beyond 2030

Dow Jones
·
Jul 28

AstraZeneca (AZN) Gets a Buy from Barclays

TIPRANKS
·
Jul 28

AstraZeneca Beats Q2 Core Earnings Forecast, Reaffirms $80 Billion Revenue Goal for 2030

Deep News
·
Jul 28

Top Midday Stories: Nvidia Enters Into $500 Billion Partnership With SK Group; AstraZeneca Earnings Top Estimates

MT Newswires Live
·
Jul 27

AstraZeneca Posts 6% Revenue Growth in First Half, Maintains Full-Year Forecast

Deep News
·
Jul 27

AstraZeneca miss ‘clear positive’ for Omeros, says H.C. Wainwright

TIPRANKS
·
Jul 27

Omeros up 11% to $10.89 after AstraZeneca study failure

TIPRANKS
·
Jul 27

AstraZeneca's Sone-Ve Significantly Extends Overall Survival in Late-Stage Gastric Cancer Phase III Trial

Deep News
·
Jul 27

Sector Update: Healthcare

MT Newswires Live
·
Jul 27

Pipeline Speed Bump Doesn't Shake AstraZeneca's $80 Billion Revenue Ambition

Benzinga Earnings
·
Jul 27

AstraZeneca Sees Potential for AI Beyond Drug Discovery

Dow Jones
·
Jul 27

AstraZeneca Wants to Move at 'Chinese Speed,' CEO Says

Dow Jones
·
Jul 27
More